CHM chimeric therapeutics limited

Ann: University of Pennsylvania joins CHM CDH17 Phase 1/2 trial, page-4

  1. 1,381 Posts.
    lightbulb Created with Sketch. 215
    Interesting. Why the ann? Its shareholder newsletter-worthy news, but not material to anything really, other than to say we are friends with a high profile Uni/Medical Research Institution.

    Is this a bottom feeding biotech attempt to stimulate sp action?
    Last edited by F18FDG: 11/09/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.747M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $10.97K 3.656M

Buyers (Bids)

No. Vol. Price($)
70 68781754 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 94220096 28
View Market Depth
Last trade - 09.59am 29/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.